Rubin J S, Qiu L, Etkind P
Department of Otorhinolaryngology, Montefiore Medical Center, Bronx, NY 10467.
J Laryngol Otol. 1995 Jan;109(1):72-6. doi: 10.1017/s0022215100129305.
Cellular oncogenes have been implicated in head and neck cancer development since 1986. More recently interest has focused on chromosome 11q13; oncogenes therein undergoing ongoing investigation include Bcl-1/Prad-1, Hst-1 and Int-2. Our laboratory has studied the Int-2 oncogene for several years, primarily in the breast. This paper presents our investigations of Int-2 in the head and neck. Thirty-four paraffin-embedded primary squamous cell carcinomas were studied for Int-2 gene amplification using a carefully controlled method of sequence quantification by DNA dot blots. Amplification, mostly low level, was identified in 62 per cent of samples studied. No clinical correlation to amplification could be found. Further studies are underway looking for evidence of expression of Int-2 in fresh tissues and for amplification and expression of other oncogenes on this amplicon.
自1986年以来,细胞癌基因就被认为与头颈癌的发生有关。最近,人们的兴趣集中在11号染色体q13区域;该区域正在进行研究的癌基因包括Bcl-1/Prad-1、Hst-1和Int-2。我们实验室对Int-2癌基因进行了数年的研究,主要是在乳腺癌方面。本文介绍了我们对头颈癌中Int-2的研究。采用精心控制的DNA斑点杂交序列定量方法,对34例石蜡包埋的原发性鳞状细胞癌进行了Int-2基因扩增研究。在所研究的样本中,62%检测到扩增,大多为低水平扩增。未发现扩增与临床之间的相关性。正在进行进一步研究,以寻找Int-2在新鲜组织中的表达证据,以及该扩增子上其他癌基因的扩增和表达证据。